EFFECT OF SPIRAPRIL ON LEFT-VENTRICULAR HYPERTROPHY DUE TO VOLUME OVERLOAD IN RATS

被引:18
|
作者
UMEMURA, K [1 ]
ZIERHUT, W [1 ]
RUDIN, M [1 ]
NOVOSEL, D [1 ]
ROBERTSON, E [1 ]
PEDERSEN, B [1 ]
HOF, RP [1 ]
机构
[1] SANDOZ PHARMA LTD,PRECLIN RES,386 416,CH-4002 BASEL,SWITZERLAND
关键词
ANGIOTENSIN-CONVERTING ENZYME INHIBITOR; CARDIAC HYPERTROPHY; MAGNETIC RESONANCE IMAGING;
D O I
10.1097/00005344-199203000-00012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effect of the angiotensin-converting enzyme (ACE) inhibitor spirapril on structural and functional parameters of volume-overloaded rat hearts was evaluated in a time-course study. Left ventricular hypertrophy (LVH) was induced by graded disruption of the aortic valve in male Wistar rats. Four weeks later, structural (LV mass and LV wall thickness) as well as functional parameters [LV end-systolic and end-diastolic volumes, stroke volume (SV), ejection fraction (EF)] were determined in anesthetized animals by magnetic resonance imaging (MRI). The rats were then divided into two groups, one of them receiving spirapril (10 mg/kg/day) in food. LV parameters were evaluated by MRI at 4, 18, 25, and 32 days after treatment was started. MRI analysis before the start of treatment showed that both groups had developed a similar degree of eccentric LV hypertrophy. Similarly, LV wall thickness, end-systolic and end-diastolic volumes, SV, and EF did not differ between the groups. Treatment with spirapril resulted in stable LV weight during the follow-up period of 32 days, whereas the untreated group showed a significant steady increase in heart weight. LV end-diastolic volume, LV end-systolic volume, and SV were smaller in the spirapril group when measured after 25 and 32 days, but only the difference in end-diastolic volume reached statistical significance. LV wall thickness and EF were not affected by spirapril. After the last MRI determinations, blood pressure (BP) and the response to angiotensin I (ANGI) were measured in conscious animals. Systolic BP (SBP) and mean arterial pressure (MAP) were significantly lower in spirapril-treated rats, and the dose-response curve to ANGI was shifted to the right. The calculated end-systolic wall tension was considerably lower in the spirapril group. In conclusion, spirapril significantly reduced LV weight and end-diastolic volume in this model. The reduction in afterload observed in the spirapril group may have been the main contributor to this effect, although other mechanisms cannot be excluded by this study.
引用
收藏
页码:375 / 381
页数:7
相关论文
共 50 条
  • [1] DIETARY-SODIUM INTAKE AND LEFT-VENTRICULAR HYPERTROPHY IN NORMOTENSIVE RATS
    YUAN, BX
    LEENEN, FHH
    AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (05): : H1397 - H1401
  • [2] REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY - A METAANALYSIS
    DAHLOF, B
    PENNERT, K
    HANSSON, L
    CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1992, 14 (1-2) : 173 - 180
  • [3] The effect of antisense to NF-κB in an albumin microsphere formulation on the progression of left-ventricular remodeling associated with chronic volume overload in rats
    Patel, Neil
    Addo, Richard T.
    Ubale, Ruhi
    Uddin, Mohammed Nasir
    D'Souza, Martin
    Jobe, Lynetta
    JOURNAL OF DRUG TARGETING, 2014, 22 (09) : 796 - 804
  • [4] REDUCTION BY ORAL PROPRANOLOL TREATMENT OF LEFT-VENTRICULAR HYPERTROPHY SECONDARY TO PRESSURE-OVERLOAD IN THE RAT
    OSTMANSMITH, I
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (06) : 2703 - 2709
  • [5] Effects of dantrolene sodium on progression of left ventricular hypertrophy induced by pressure overload in rats
    Ohkusa, T
    Hisamatsu, Y
    Ueyama, T
    Kobayashi, S
    Yano, M
    Maekawa, T
    Matsuzaki, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 (04) : 520 - 524
  • [6] Effect of Pentraxin 3 on Pressure Overload-Induced Left Ventricular Hypertrophy
    Suzuki, Satoshi
    Shishido, Tetsuro
    Funayama, Akira
    Netsu, Shunsuke
    Takeishi, Yasuchika
    CIRCULATION RESEARCH, 2012, 111 (04)
  • [7] TREATMENT OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS
    TAMARGO, J
    DELPON, E
    VALENZUELA, C
    EUROPEAN HEART JOURNAL, 1993, 14 : 102 - 106
  • [8] Regression of left ventricular hypertrophy under spirapril treatment investigated by nuclear magnetic resonance imaging
    Eichstadt, H
    Moersler, J
    Jochens, R
    Amthauer, H
    Schumacher, T
    Klefisch, F
    Mockel, M
    Stork, T
    Scholz, J
    Weidinger, G
    PERFUSION, 1996, 9 (09): : 338 - 343
  • [9] Assessment of left ventricular structure and function in rats subjected to pressure-overload hypertrophy in time
    Stoyanova, Vili
    Zhelev, Nikolai
    Ghenev, Evghenii
    Bosheva, Miroslava
    KARDIOLOGIA POLSKA, 2009, 67 (01) : 27 - 35
  • [10] REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY AFTER MOXONIDIN THERAPY
    EICHSTADT, H
    GATZ, G
    SCHRODER, R
    KREUZ, D
    PERFUSION, 1992, 5 (1-2): : 8 - &